|
End-of-day quote
Nasdaq Stockholm
21/10/2026
|
5-day change | 1st Jan Change | ||
| 3.225 SEK | +1.10% |
|
-1.98% | -29.89% |
| 10-13 | Active Biotech completes first safety cohort in study of tasquinimod | FW |
| 10-13 | Active Biotech completes first safety cohort in myelofibrosis study | FW |
Chart: Technical Analysis
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| ACTI | End-of-day quote | |
Nasdaq Stockholm
| ACTI | Delayed | |
|
Deutsche Boerse AG
| BTP | Delayed | |
|
CBOE
| 0GQU | Real-time | |
|
Börse Stuttgart
| BTP | Delayed | |
|
CBOE
| ACTIs | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 3.79 | 5.1 | 5.12 |
| Spread/Res. | -14.91% | -36.76% | -37.01% |
| Spread/Supp. | +3.70% | +3.70% | +2.87% |
| Support | 3.11 | 3.11 | 3.135 |
- Stock Market
- Stocks
- ACTI Stock
- Charts Active Biotech AB
Select your edition
All financial news and data tailored to specific country editions
